Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,761 to 1,780 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis. | Front Immunol | 2021 | 34777388 | PubTator, text mining | PubMed |
| Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer. | Front Immunol | 2021 | 34777359 | PubTator, text mining | PubMed |
Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines. | Front Immunol | 2021 | 34777330 | PubTator, text mining | PubMed |
| BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation. | Int J Mol Sci | 2021 | 34769379 | PubTator, text mining | PubMed |
| Contribution of Dysregulated DNA Methylation to Autoimmunity. | Int J Mol Sci | 2021 | 34769338 | PubTator, text mining | PubMed |
| Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders. | Int J Mol Sci | 2021 | 34768899 | PubTator, text mining | PubMed |
| Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer. | BMC Cancer | 2021 | 34763648 | PubTator, text mining | PubMed |
| T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges. | Front Oncol | 2021 | 34760690 | PubTator, text mining | PubMed |
| [Mechanisms and prevention strategies of relapse and resistance after BCMA-CAR-T cell in multiple myeloma]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 34753237 | PubTator, text mining | PubMed |
| A Dynamic Transcriptome Map of Different Tissue Microenvironment Cells Identified During Gastric Cancer Development Using Single-Cell RNA Sequencing. | Front Immunol | 2021 | 34745098 | PubTator, text mining | PubMed |
| Targeting lysosomes in human disease: from basic research to clinical applications. | Signal Transduct Target Ther | 2021 | 34744168 | PubTator, text mining | PubMed |
Longitudinal Assessment of Physical Activity, Fitness, Body Composition, Immunological Biomarkers, and Psychological Parameters During the First Year After Diagnosis in Women With Non-Metastatic Breast Cancer: The BEGYN Study Protocol. | Front Oncol | 2021 | 34737966 | PubTator, text mining | PubMed |
| Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer. | Front Oncol | 2021 | 34733794 | PubTator, text mining | PubMed |
| Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics. | Mol Ther Methods Clin Dev | 2021 | 34729382 | PubTator, text mining | PubMed |
| Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development. | Acta Pharm Sin B | 2021 | 34729298 | PubTator, text mining | PubMed |
| A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma. | Dis Markers | 2021 | 34721731 | PubTator, text mining | PubMed |
| Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of NFKB1 Knockout THP1 Cells. | Front Immunol | 2021 | 34721373 | PubTator, text mining | PubMed |
| Baboon Envelope Pseudotyped "Nanoblades" Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells. | Front Genome Ed | 2021 | 34713246 | PubTator, text mining | PubMed |
| Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment. | Front Genet | 2021 | 34712264 | PubTator, text mining | PubMed |
| Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients. | Sci Transl Med | 2021 | 34705520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=89